School of Medicine


Showing 1-10 of 10 Results

  • Saad A. Khan, MD

    Saad A. Khan, MD

    Assistant Professor of Medicine (Oncology) at the Stanford University Medical Center

    Bio Saad A. Khan, MD is a medical oncologist focused on the treatment of head and neck, thyroid and lung cancers. His research interests include therapeutic clinical trials as well as mechanisms of reducing toxicities that patients experience. His research activities include ongoing clinical trials of targeted and immune therapy in aggressive thyroid malignancies. He is a member of the NRG Head and Neck Committee, the ECOG Head and Neck Core and Thoracic Committees and the National Cancer Institute?s Head and Neck Steering Committee Rare Tumor Task Force.

    When not in clinic or the hospital he enjoys spending time with his family and 3 children, hiking and sitting on the beach.

  • Youn H Kim, MD

    Youn H Kim, MD

    The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Clinical research in cutaneous lymphomas, especially, mycosis fungoides; studies of prognostic factors, long-term survival results, and effects of therapies. Collaborative research with Departments of Pathology and Oncology in basic mechanisms of cutaneous lymphomas. Clinical trials of new investigative therapies for various dermatologic conditions or clinical trials of known therapies for new indications.

  • Daniel Alexander King

    Daniel Alexander King

    Postdoctoral Medical Fellow, Oncology

    Bio Daniel Alexander King, MD, PhD (Oncology Fellow)

    Originally from Long Island, NY, Dan trained at Cold Spring Harbor Laboratory, the University of Michigan (BS), Wayne State University (MD), the National Human Genome Research Institute (HHMI Research Scholars Program), Cambridge University (PhD), and Columbia University (Internal Medicine Residency). He enjoys mutation hunting in large-scale genomic data. He was most recently involved in an exome sequencing study of 12,000 children with rare disease and their parents, in which he developed new computational tools to identify large genetic aberrations. His mutational spectrum of interest includes uniparental disomy, copy number alterations, and mosaicism. He plans to explore research opportunities riding the intersection of new technology & genomics, such as single cell DNA & RNA sequencing, and circulating tumor DNA.
    During oncology fellowship he has developed a passion for pancreatic cancer and specializes in caring for patients with pancreatic cancer in clinic with renowned medical oncologist Dr George Fisher. During fellowship his pancreatic research interests span the spectrum of translational research in pancreatic cancer. Several recent accomplishments include: 1) the development of a pancreatic cancer-specific circulating tumor DNA assay, the development of a pancreatic cancer research database containing thousands of patients who presented to Stanford with pancreatic cancer over the last twenty years, and the development of a large +500 sample biobank consisting of blood samples from generous pancreatic cancer patient study participants.

  • Shivaani Kummar

    Shivaani Kummar

    Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Kummar?s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.

  • Allison W. Kurian, M.D., M.Sc.

    Allison W. Kurian, M.D., M.Sc.

    Associate Professor of Medicine (Oncology) and of Epidemiology and Population Health at the Stanford University Medical Center

    Current Research and Scholarly Interests I aim to improve the outcomes of women's cancers through clinically-oriented research on genetic risk assessment, risk-adapted screening and prevention.

  • David Kurtz

    David Kurtz

    Instructor, Medicine - Oncology

    Current Research and Scholarly Interests Implementation of noninvasive detection of malignancies in the clinic remains difficult due to both technical and clinical challenges. These include necessary improvements in sensitivity and specificity of biomarkers, as well as demonstration of clinical utility of these assays. My research focuses on technical development and implementation of assays to detect and track cancers in order to facilitate personalized disease management.

Footer Links:

Stanford Medicine Resources: